Stevanato Group S.p.A. $STVN Shares Purchased by T. Rowe Price Investment Management Inc.

Key Points

• T. Rowe Price Investment Management Inc. increased its stake in Stevanato Group S.p.A. by 13.3% in Q1, holding 3,744,714 shares valued at approximately $76.47 million.
• Multiple institutional investors, including Whittier Trust Co. and Wells Fargo, have recently adjusted their positions in Stevanato Group, indicating increased interest in the company.
• Stevanato Group has received a consensus rating of "Moderate Buy" from analysts, with one analyst stating a Strong Buy and others assigning Buy and Hold ratings.

T. Rowe Price Investment Management Inc. lifted its holdings in Stevanato Group S.p.A. (NYSE:STVN - Free Report) by 13.3% in the first quarter, according to its most recent disclosure with the SEC. The institutional investor owned 3,744,714 shares of the company's stock after purchasing an additional 439,722 shares during the period. T. Rowe Price Investment Management Inc. owned approximately 1.24% of Stevanato Group worth $76,468,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Bessemer Group Inc. grew its holdings in shares of Stevanato Group by 14,623.3% in the first quarter. Bessemer Group Inc. now owns 13,251 shares of the company's stock valued at $270,000 after purchasing an additional 13,161 shares in the last quarter. Palisade Capital Management LP grew its holdings in Stevanato Group by 52.0% during the 1st quarter. Palisade Capital Management LP now owns 91,431 shares of the company's stock worth $1,867,000 after acquiring an additional 31,283 shares in the last quarter. D. E. Shaw & Co. Inc. acquired a new position in Stevanato Group during the 4th quarter worth approximately $281,000. Envestnet Asset Management Inc. grew its holdings in Stevanato Group by 16.9% during the 1st quarter. Envestnet Asset Management Inc. now owns 162,770 shares of the company's stock worth $3,324,000 after acquiring an additional 23,545 shares in the last quarter. Finally, Yarbrough Capital LLC acquired a new position in Stevanato Group during the 1st quarter worth approximately $329,000.

Analysts Set New Price Targets

Separately, William Blair reiterated an "outperform" rating on shares of Stevanato Group in a report on Monday, June 30th. One equities research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy".

Stevanato Group Stock Performance

NYSE:STVN traded up €0.65 during trading hours on Wednesday, reaching €22.30. 152,602 shares of the company's stock were exchanged, compared to its average volume of 336,168. The firm has a market capitalization of $6.75 billion, a price-to-earnings ratio of 41.30, a P/E/G ratio of 2.07 and a beta of 0.55. The company has a 50-day moving average of €24.25 and a 200 day moving average of €22.49. The company has a quick ratio of 1.22, a current ratio of 1.79 and a debt-to-equity ratio of 0.25. Stevanato Group S.p.A. has a 1-year low of €17.12 and a 1-year high of €28.00.

Stevanato Group Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.